Yes, totally agree - variations in health care cost and coverage probably also account for the differences in OA prevalence between USA/UK/Australia
"The best indicators in my mind are CSL and companies such as SRX and now CUV....."
A new CSL would be a dream - I bought CSL in the float 25 years ago at 78c (adjusting for the 3 for 1 split) - if PAR performs as well as CSL, then in 25 years we'll be looking at a share price of about $380
(Just having a bit of fun here......)
PAR -v- CUV, page-32
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $93.93K | 463.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33196 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 104053 | 8 |
View Market Depth
| Last trade - 11.33am 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |